Review

Is radical cystectomy the gold standard?

• Binhan Kağan Aktaş
• Ali Memiş

Bladder cancer epidemiology in the world and in Tukey

• Sultan Eser
• Raziye Özdemir

• Ziya Kirkali
• Emre Tüzel
• Ahmet Gençbay

Prognostic factors in renal cancer and prediction models

• Ümit Gül
• Özgür Yaycıoğlu

Düşük riskli prostat kanserine yaklaşım ve aktif izlem

• Ahmet Soylu

Böbrek kanserinde prognostik faktörler ve öngörü modelleri

• Özgür Yaycıoğlu

Benign prostat hiperplazisi ve progresyonunda risk faktörleri

• Gürkan Çoban
• İbrahim Cüreklibatır

Genetik alteration in bladder carcinoma

• Hakan Akça
• Onur Tokgün

Geometry of cancer and fractals in bladder cancer

• Fehmi Narter
• Osman Köse

• Kutsal Yörükoglu

Prostat kanserinde aktif izlem güvenilir bir metot mudur?

• M. Selçuk Keskin
• Süleyman Ataus

• Çag Çal

Treatment of small renal masses: Where we are in 2011

• Mutlu Ateş
• Mustafa Karalar
• Engin Doğantekin

TUR prostat sonrası gelişen hiperaktif mesane bulguları neden oluyor, nasıl tedavi etmeli?

• Ceyhun Özyurt

Bipolar veya plazmakinetik enerji ile yapılan TUR-M operasyonlarının klasik metottan farkı var mı?

• Binhan Kağan Aktaş
• Mehmet Murat Baykam

Has DNA methylation any impact in prostate cancer diagnosis?

• Buket Kosova
• Rukiye Özel
• Çağdaş Aktan

Importance of mycobacteria in treatment of bladder tumor

• Esra Büber
• Selçuk Keskin
• N. Leyla Açan

Active Surveillance: Treatment Modality that Expect Attention for Localized Prostate Cancer

• Tayyar Alp Özkan
• Özdal Dillioğlugil

Diagnosis and management of the strictures after prostatectomy

• Murat Akand
• Serdar Göktaş

How affected Active Surveillance the quality of life in low-risk localized prostate cancer?

• İlker Çelen
• Sinharib Çitgez
• Talha Müezzinoğlu

Active surveillance in low risk prostate cancer

• Ozan Bozkurt
• Ömer Demir

Treatment options in low-intermediate risk prostate cancer

• Saadettin Yılmaz Eskiçorapçı
• Deniz Bolat

Comparison of the Clinical and Pathologic Staging in Patients Undergoing Radical Cystectomy, the Factors Associated with Upstaging and its Effect on Outcome

• Polat Türker

Active surveillance for localized prostate cancer

• İlker Tınay
• Levent Türkeri

Relationship between active surveillance / watchfull waiting and quality of life in localised prostate cancer

• İlker Çelen
• Yasin Ceylan

Active Surveillance in Prostate Cancer

• Volkan İzol
• Nebil Akdoğan

Risk Factors and Etiology in Renal Cell Carcinoma

• Ümit Gül

Risk Factors for Urothelial Cancers

• Ümit Gül
• Barış Kuzgunbay

Active Surveillance-Factors Affecting the Treatment Decision: 3M: “Marker”, “Mapping”, “MRI”

• Ender Özden
• Mehmet Necmettin Mercimek

Active Surveillance in Prostate Cancer: Can We Expand the Indications?

• Hacı Murat Akgül
• Asgar Garayev
• İlker Tinay

Testicular tumors in elderly men

• Deniz Bolat
• Tevfik Haktanır
• Mehmet Ali Ergül

Follow-up principles after curative treatment in renal cancer

• Ercan Kazan
• Hakan Gemalmaz

Active surveillence in small kidney tumors

• Yasin Ceylan
• Bülent Günlüsoy

Article - Comment

Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo

• Turgut Alkibay

Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance

• Kadir Baykal
• Cüneyt Adayener

P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors

• Kadir Türkölmez

Active surveillance of small renal masses: progression patterns of early stage kidney cancer

• Nurşen Atasoy
• Semih Ayan

Quality Of Life

Male lower urinary tract symptoms: An update – overactive bladder or not ?

• Tufan Tarcan
• İlker Tınay

Bph

Antimuscarinics in the treatment of overactive bladder: does one fit all? Can treatment be individualized?

• Ceyhun Özyurt

General Urooncology

Does physical activity decrease incidence of urooncologic cancers?

• Evren Süer
• Çağatay Göğüs